LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Colorado on behalf of a class (the “Class”) comprising purchasers of the securities ...
Shares of Venaxis, Inc. (NASDAQ:APPY) rose by 7.53% in the past week and 7.29% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 8.27% and the outperformance increases to 8.49% for the last 4 weeks.
These forward-looking statements are qualified by the cautionary statements contained in Venaxis' news releases and SEC filings, including its Annual Report on Form 10-K for the year ended December 31, 2014, which Venaxis filed on March 30, 2015.
Venaxis, Inc. shares have received a Mean Price Target of $0.75. According to the rating issued from 2 Wall Street Analysts, the High Price Target is seen at $1 while the Lower end of the Price Target is seen at $0.5.
Venaxis, Inc. (NASDAQ:APPY) has lost 17.39% during the past week and dropped 17.08% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 17.06%.